These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32659223)

  • 1. Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma.
    Silsirivanit A; Matsuda A; Kuno A; Tsuruno C; Uenoyama Y; Seubwai W; Angata K; Teeravirote K; Wongkham C; Araki N; Takahama Y; Wongkham S; Narimatsu H
    Clin Chim Acta; 2020 Nov; 510():142-149. PubMed ID: 32659223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma.
    Tang Z; Yang Y; Wang X; Meng W; Li X
    BMJ Open; 2019 Jan; 9(1):e021693. PubMed ID: 30700476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum α2,6-sialylated glycoform of serotransferrin as a glycobiomarker for diagnosis and prediction of clinical severity in cholangiocarcinoma.
    Kimawaha P; Thanan R; Jusakul A; Jamnongkan W; Silsirivanit A; Sa-Ngaimwibool P; Titapun A; Khuntikeo N; Sithithaworn P; Worasith C; Janthamala S; Lebrilla CB; Techasen A
    Clin Chim Acta; 2022 Nov; 536():142-154. PubMed ID: 36174722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CA-S27: a novel Lewis a associated carbohydrate epitope is diagnostic and prognostic for cholangiocarcinoma.
    Silsirivanit A; Araki N; Wongkham C; Vaeteewoottacharn K; Pairojkul C; Kuwahara K; Narimatsu Y; Sawaki H; Narimatsu H; Okada S; Sakaguchi N; Wongkham S
    Cancer Sci; 2013 Oct; 104(10):1278-84. PubMed ID: 23809433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
    Shoda J; Matsuda A; Shida T; Yamamoto M; Nagino M; Tsuyuguchi T; Yasaka T; Tazuma S; Uchiyama K; Unno M; Ohkohchi N; Nakanuma Y; Kuno A; Narimatsu H
    J Gastroenterol; 2017 Feb; 52(2):218-228. PubMed ID: 27358229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by
    Teeravirote K; Luang S; Waraasawapati S; Boonsiri P; Wongkham C; Wongkham S; Silsirivanit A
    Molecules; 2021 May; 26(9):. PubMed ID: 34066878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of GalNAcylated glycans in cholangiocarcinoma: Values for diagnosis and prognosis.
    Saentaweesuk W; Silsirivanit A; Vaeteewoottacharn K; Sawanyawisuth K; Pairojkul C; Cha'on U; Indramanee S; Pinlaor S; Boonmars T; Araki N; Wongkham C
    Clin Chim Acta; 2018 Feb; 477():66-71. PubMed ID: 29217428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics analysis and evaluation of biomarkers for detection of cholangiocarcinoma.
    Sriwanitchrak P; Viyanant V; Chaijaroenkul W; Srivatanakul P; Gram HR; Eursiddhichai V; Na-Bangchang K
    Asian Pac J Cancer Prev; 2011; 12(6):1503-10. PubMed ID: 22126489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State of serum markers for detection of cholangiocarcinoma.
    Wongkham S; Silsirivanit A
    Asian Pac J Cancer Prev; 2012; 13 Suppl():17-27. PubMed ID: 23480761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Bile Titer and High Bile to Serum Ratio of CYFRA 21 - 1 Reliably Discriminate Malignant Biliary Obstruction Caused by Cholangiocarcinoma.
    Chen J; Liang J; Xu B; Liang J; Ma M; Wang Z; Zeng G; Xu Q; Liang L; Lai J; Huang L
    J Gastrointest Cancer; 2024 Jun; 55(2):800-808. PubMed ID: 38280173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbohydrate Antigen 50: Values for Diagnosis and Prognostic Prediction of Intrahepatic Cholangiocarcinoma.
    Luang S; Teeravirote K; Saentaweesuk W; Ma-In P; Silsirivanit A
    Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33207685
    [No Abstract]   [Full Text] [Related]  

  • 12. Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach.
    Pattanapairoj S; Silsirivanit A; Muisuk K; Seubwai W; Cha'on U; Vaeteewoottacharn K; Sawanyawisuth K; Chetchotsak D; Wongkham S
    Clin Biochem; 2015 Jul; 48(10-11):668-73. PubMed ID: 25863112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
    Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
    Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoproteomics-based cancer marker discovery adopting dual enrichment with Wisteria floribunda agglutinin for high specific glyco-diagnosis of cholangiocarcinoma.
    Matsuda A; Kuno A; Matsuzaki H; Kawamoto T; Shikanai T; Nakanuma Y; Yamamoto M; Ohkohchi N; Ikehara Y; Shoda J; Hirabayashi J; Narimatsu H
    J Proteomics; 2013 Jun; 85():1-11. PubMed ID: 23612463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Accuracy of Serum CA19-9 in Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
    Liang B; Zhong L; He Q; Wang S; Pan Z; Wang T; Zhao Y
    Med Sci Monit; 2015 Nov; 21():3555-63. PubMed ID: 26576628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma.
    Jiang Y; Zheng X; Jiao D; Chen P; Xu Y; Wei H; Qian Y
    EBioMedicine; 2019 Feb; 40():422-431. PubMed ID: 30638862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristic Features of Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis.
    Ishii Y; Sasaki T; Serikawa M; Kobayashi K; Kamigaki M; Minami T; Okazaki A; Yukutake M; Ishigaki T; Kosaka K; Mouri T; Yoshimi S; Chayama K
    Hepatogastroenterology; 2014 May; 61(131):567-73. PubMed ID: 26176037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma.
    Lertpanprom M; Silsirivanit A; Tippayawat P; Proungvitaya T; Roytrakul S; Proungvitaya S
    Front Public Health; 2022; 10():835914. PubMed ID: 35991009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Wannhoff A; Hov JR; Folseraas T; Rupp C; Friedrich K; Anmarkrud JA; Weiss KH; Sauer P; Schirmacher P; Boberg KM; Stremmel W; Karlsen TH; Gotthardt DN
    J Hepatol; 2013 Dec; 59(6):1278-84. PubMed ID: 23958938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum markers of intrahepatic cholangiocarcinoma.
    Malaguarnera G; Paladina I; Giordano M; Malaguarnera M; Bertino G; Berretta M
    Dis Markers; 2013; 34(4):219-28. PubMed ID: 23396291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.